CN110746514B - 一种黑果枸杞多糖的提取方法及其应用 - Google Patents
一种黑果枸杞多糖的提取方法及其应用 Download PDFInfo
- Publication number
- CN110746514B CN110746514B CN201910985328.6A CN201910985328A CN110746514B CN 110746514 B CN110746514 B CN 110746514B CN 201910985328 A CN201910985328 A CN 201910985328A CN 110746514 B CN110746514 B CN 110746514B
- Authority
- CN
- China
- Prior art keywords
- polysaccharide
- lycium ruthenicum
- powder
- extraction
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 115
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 107
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 107
- 241000169546 Lycium ruthenicum Species 0.000 title claims abstract description 102
- 238000000605 extraction Methods 0.000 title claims description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 38
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 25
- 239000012153 distilled water Substances 0.000 claims abstract description 19
- 238000003756 stirring Methods 0.000 claims abstract description 18
- 238000001035 drying Methods 0.000 claims abstract description 17
- 238000001914 filtration Methods 0.000 claims abstract description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000047 product Substances 0.000 claims abstract description 13
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 10
- 239000002244 precipitate Substances 0.000 claims abstract description 7
- 239000012065 filter cake Substances 0.000 claims abstract description 5
- 239000011347 resin Substances 0.000 claims abstract description 5
- 229920005989 resin Polymers 0.000 claims abstract description 5
- 238000005406 washing Methods 0.000 claims abstract description 5
- 230000000719 anti-leukaemic effect Effects 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 18
- 235000019441 ethanol Nutrition 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 10
- 238000000967 suction filtration Methods 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 8
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 abstract description 25
- 108090000623 proteins and genes Proteins 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 12
- 230000006907 apoptotic process Effects 0.000 abstract description 11
- 230000006667 mitochondrial pathway Effects 0.000 abstract description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract description 7
- 238000002791 soaking Methods 0.000 abstract description 5
- 238000010438 heat treatment Methods 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 23
- 238000002474 experimental method Methods 0.000 description 17
- 239000012528 membrane Substances 0.000 description 14
- 239000002033 PVDF binder Substances 0.000 description 12
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- 239000008103 glucose Substances 0.000 description 11
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 230000001086 cytosolic effect Effects 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000005303 weighing Methods 0.000 description 7
- 238000001962 electrophoresis Methods 0.000 description 6
- 239000003292 glue Substances 0.000 description 6
- 238000000751 protein extraction Methods 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- 239000006180 TBST buffer Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 208000032839 leukemia Diseases 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 4
- 101150000251 xiap gene Proteins 0.000 description 4
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 3
- 102400000888 Cholecystokinin-8 Human genes 0.000 description 3
- 101800005151 Cholecystokinin-8 Proteins 0.000 description 3
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 3
- 108010033040 Histones Proteins 0.000 description 3
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 3
- 108700000707 bcl-2-Associated X Proteins 0.000 description 3
- 102000055102 bcl-2-Associated X Human genes 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 238000007670 refining Methods 0.000 description 3
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- 229940088872 Apoptosis inhibitor Drugs 0.000 description 2
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 239000000158 apoptosis inhibitor Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- -1 ketone compounds Chemical class 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 230000036210 malignancy Effects 0.000 description 2
- 210000001700 mitochondrial membrane Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 241000755266 Kathetostoma giganteum Species 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 108010089610 Nuclear Proteins Proteins 0.000 description 1
- 102000007999 Nuclear Proteins Human genes 0.000 description 1
- 241001237823 Paenibacillus vortex Species 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 101710170789 Protein bax Proteins 0.000 description 1
- 108010090931 Proto-Oncogene Proteins c-bcl-2 Proteins 0.000 description 1
- 102000013535 Proto-Oncogene Proteins c-bcl-2 Human genes 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Natural products C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 1
- 230000006909 anti-apoptosis Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 201000002797 childhood leukemia Diseases 0.000 description 1
- 208000024207 chronic leukemia Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000025113 myeloid leukemia Diseases 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000009828 non-uniform distribution Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Public Health (AREA)
- Sustainable Development (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
DMSO体积 | 10mL | 20mL | 30mL | 40mL | 50mL |
得率 | 30.57% | 32.69% | 43.27% | 58.76% | 66.34% |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910985328.6A CN110746514B (zh) | 2019-10-16 | 2019-10-16 | 一种黑果枸杞多糖的提取方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910985328.6A CN110746514B (zh) | 2019-10-16 | 2019-10-16 | 一种黑果枸杞多糖的提取方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110746514A CN110746514A (zh) | 2020-02-04 |
CN110746514B true CN110746514B (zh) | 2021-07-09 |
Family
ID=69278683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910985328.6A Active CN110746514B (zh) | 2019-10-16 | 2019-10-16 | 一种黑果枸杞多糖的提取方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110746514B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113952264B (zh) * | 2021-07-23 | 2022-07-29 | 太和康美(北京)中医研究院有限公司 | 黑枸杞提取物在制备护肤品中的应用、护肤品 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1686421A (zh) * | 2005-04-26 | 2005-10-26 | 陶燕铎 | 黑果枸杞植物果实提取物及其制备方法和应用 |
CN103159864A (zh) * | 2011-12-19 | 2013-06-19 | 中国科学院大连化学物理研究所 | 一种黑果枸杞多糖的分离纯化方法及分离得到的五种多糖 |
CN104987427A (zh) * | 2015-07-23 | 2015-10-21 | 中国科学院西北高原生物研究所 | 利用响应曲面法优化黑果枸杞多糖的复合酶微波提取方法 |
CN105218695A (zh) * | 2015-10-28 | 2016-01-06 | 青海尤尼克生物技术有限公司 | 一种黑果枸杞多糖提取物及其制备方法 |
CN106728369A (zh) * | 2016-12-15 | 2017-05-31 | 防城港市蓝瀚达科技有限公司 | 一组有效治疗白血病的中药 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106668811A (zh) * | 2016-12-20 | 2017-05-17 | 苟春虎 | 黑枸杞抗癌救生片 |
-
2019
- 2019-10-16 CN CN201910985328.6A patent/CN110746514B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1686421A (zh) * | 2005-04-26 | 2005-10-26 | 陶燕铎 | 黑果枸杞植物果实提取物及其制备方法和应用 |
CN103159864A (zh) * | 2011-12-19 | 2013-06-19 | 中国科学院大连化学物理研究所 | 一种黑果枸杞多糖的分离纯化方法及分离得到的五种多糖 |
CN104987427A (zh) * | 2015-07-23 | 2015-10-21 | 中国科学院西北高原生物研究所 | 利用响应曲面法优化黑果枸杞多糖的复合酶微波提取方法 |
CN105218695A (zh) * | 2015-10-28 | 2016-01-06 | 青海尤尼克生物技术有限公司 | 一种黑果枸杞多糖提取物及其制备方法 |
CN106728369A (zh) * | 2016-12-15 | 2017-05-31 | 防城港市蓝瀚达科技有限公司 | 一组有效治疗白血病的中药 |
Non-Patent Citations (3)
Title |
---|
Lycium ruthenicum polysaccharide attenuates inflammation through inhibiting TLR4/NF-B-kappa signaling pathway;Peng, Qiang等;《INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES》;20140325;第330-335页 * |
响应面法优化黑果枸杞多糖的提取工艺研究;鲁小静等;《中国酿造》;20130615;第79-83页 * |
茯苓多糖提取方法研究;高杰等;《吉林中医药》;20070920;第60页 * |
Also Published As
Publication number | Publication date |
---|---|
CN110746514A (zh) | 2020-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103222988B (zh) | 一种美洲大蠊提取物及其制备方法和应用 | |
CN103145780A (zh) | 一种蓝莓花色苷的制备方法与所制备的蓝莓花色苷的应用 | |
CN110746514B (zh) | 一种黑果枸杞多糖的提取方法及其应用 | |
WO2018166240A1 (zh) | 一种太平洋牡蛎中性多糖及其制备方法和应用 | |
CN115634241A (zh) | 一种山东灵芝提取物的制备方法及其在制备降血糖药物中的应用 | |
CN111150752A (zh) | 鸡骨草提取物在制备抗癌药物中的应用 | |
CN113599412A (zh) | 党参黄芪组合物在制备预防和治疗晚期肿瘤相关症状的药物中的用途 | |
CN106942737A (zh) | 沙棘黄酮及其应用 | |
CN112851615A (zh) | 一种异戊烯基黄酮的制备及其作为治疗宫颈癌药物的应用 | |
CN115746166B (zh) | 一种蒌叶果胶及其制备方法与应用 | |
CN109248205B (zh) | 毛叶蔷薇果实提取物的用途 | |
CN110452948A (zh) | 鹿心蛋白水解物及其制备方法和应用 | |
CN109045085A (zh) | 荨麻提取物及在制备治疗抗过敏的药物上的应用 | |
CN113527423B (zh) | 一种辅助治疗nafld的南极磷虾寡肽及其应用 | |
CN115286597B (zh) | 一种沙棘籽粕中5-羟色胺的分离制备方法及用途 | |
CN115671260A (zh) | 药物组合物、培养基和诱导肿瘤细胞成脂分化的方法 | |
CN110251502B (zh) | 一种岩藻黄素在抗甲减中的应用 | |
CN106699855A (zh) | 一种蛋白质及其分离方法与应用 | |
CN114181325A (zh) | 黑色素合成抑制剂及其美白用途 | |
CN106053409B (zh) | 一种检测红肉苹果花青苷降低猪卵巢颗粒细胞内活性氧的方法 | |
CN111303103A (zh) | 一种星毛冠盖藤总香豆素的制备方法及其应用 | |
CN118063528A (zh) | 黑果枸杞中的矮牵牛素类衍生物secopetanin及其提取方法和用途 | |
Hou et al. | Effects of LP on Immune Function and Intestinal Flora in Immunosuppressive Mice | |
CN117297005A (zh) | 一种护肝醒酒组合物及其制备方法与应用 | |
CN114181324A (zh) | 一种美白淡斑物质的制备和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221103 Address after: 230000 Room 203, building 2, phase I, e-commerce Park, Jinggang Road, Shushan Economic Development Zone, Hefei City, Anhui Province Patentee after: Hefei Jiuzhou Longteng scientific and technological achievement transformation Co.,Ltd. Address before: Cao Shan Road Anhui city Bengbu province 233030 Longzihu District No. 1866 Patentee before: BENGBU College |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221213 Address after: Room 103-309, Building 26, Nangang Cluster (180 Hongqi Street), Harbin Hi tech Industrial Development Zone, 150000 Heilongjiang Patentee after: Heilongjiang bangchao Biotechnology Co.,Ltd. Address before: 230000 Room 203, building 2, phase I, e-commerce Park, Jinggang Road, Shushan Economic Development Zone, Hefei City, Anhui Province Patentee before: Hefei Jiuzhou Longteng scientific and technological achievement transformation Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240426 Address after: Room B107-31, Building 19, Innovation and Entrepreneurship Plaza, Science and Technology Innovation City, Harbin High tech Industrial Development Zone, Heilongjiang Province, 150000 RMB (No. 699 Chuangxin Road) Patentee after: Heilongjiang Strict Innovation Yundou Technology Co.,Ltd. Country or region after: China Address before: Room 103-309, Building 26, Nangang Cluster (180 Hongqi Street), Harbin Hi tech Industrial Development Zone, 150000 Heilongjiang Patentee before: Heilongjiang bangchao Biotechnology Co.,Ltd. Country or region before: China |